Table 3 Univariable logistic regressions of potentially associated factors for beta-blocker prescription.
Variables | Unadjusted odds ratios | 95% confidence intervals | p |
---|---|---|---|
Age | 0.96 | 0.93–0.99 | 0.008 |
Sex (female vs. male) | 1.65 | 0.93–2.94 | 0.090 |
NYHA classes (from II to IV) | 0.41 | 0.22–0.74 | 0.003 |
Heart rate < 65 bpm | 0.31 | 0.11–0.84 | 0.021 |
Hypertension | 1.63 | 0.75–3.52 | 0.219 |
Ischemic heart disease | 1.59 | 0.77–3.28 | 0.206 |
Atrial fibrillation | 0.81 | 0.44–1.50 | 0.498 |
Diabetes | 0.99 | 0.55–1.82 | 0.994 |
Dyslipidemia | 1.16 | 0.63–2.11 | 0.640 |
Valvular heart disease | 1.30 | 0.48–3.52 | 0.601 |
Dilated cardiomyopathy | 0.63 | 0.17–2.44 | 0.507 |
Chronic kidney disease | 0.31 | 0.16–0.63 | 0.001 |
Chronic obstructive pulmonary disease | 0.13 | 0.03–0.61 | 0.009 |
Obesity (body mass index ≥ 30) | 0.26 | 0.03–2.57 | 0.251 |